Morphine Sulfate
NDC Package 67296-1483-7
Package Information
Morphine Sulfate is oral solution 100 mg per 5 mL (20 mg/mL) is indicated for the relief of acute and chronic pain in opioid-tolerant adult patients.Limitations of Use: Because of the risks of addiction, abuse, and misuse with opioids, which can occur at any dosage or duration [see Warnings and Precautions ( 5.2)] , reserve morphine sulfate oral solution for use in patients for whom alternative treatment options (e.g., non-opioid analgesics or opioid combination products): Have not been tolerated or are not expected to be tolerated,Have not provided adequate analgesia or are not expected to provide adequate analgesia.Morphine sulfate oral solution should not be used for an extended period of time unless the pain remains severe enough to require an opioid analgesic and for which alternative treatment options continue to be inadequate.Pediatric use information is approved for Hikma Pharmaceuticals USA Inc.’s morphine sulfate oral solution. Marketed by Redpharm Drug, this product is identified by NDC 67296-1483 and is authorized under FDA application ANDA202348.
Identification & Billing
- RxCUI: 892625 - morphine sulfate 20 MG in 1 mL Concentrate for Oral Solution
- RxCUI: 892625 - morphine sulfate 20 MG/ML Oral Solution
- RxCUI: 892625 - morphine sulfate 10 MG per 0.5 ML Concentrate for Oral Solution
- RxCUI: 892625 - morphine sulfate 100 MG per 5 ML Concentrate for Oral Solution
- RxCUI: 892625 - morphine sulfate 20 MG/ML Concentrate for Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 67296 - Redpharm Drug
- 67296-1483 - Morphine Sulfate
- 67296-1483-7 - 15 mL in 1 BOTTLE
- 67296-1483 - Morphine Sulfate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 67296-1483-7 identifies a specific commercial package of 15 ml in 1 bottle of Morphine Sulfate, labeled by Redpharm Drug. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Redpharm Drug on July 15, 2011. The current certification is valid through December 31, 2025.
How is this Redpharm Drug product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 67296148307. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.